Endologix AFX2 Graft Risk Information Updated in FDA-Approved Labeling
The FDA is requiring new label warnings and post-marketing studies on the Endologix AFX2 graft system, which has been linked to potentially life-threatening endoleaks.
The FDA is requiring new label warnings and post-marketing studies on the Endologix AFX2 graft system, which has been linked to potentially life-threatening endoleaks.
A new study finds warfarin may be safer for atrial fibrillation patients with heart disease than its newer competitor; Xarelto.
A new study warns that while Brilinta side effects can prevent vein graft failure, it also triples the risk of bleeding events.
A new study finds little difference in major bleeding events between the newer blood thinners Xarelto and Eliquis and the older blood thinner warfarin they were supposed to replace.
Covidien now faces a growing number of surgical stapler class action lawsuits in Canada, which are nearly identical to those being filed in the U.S. over complications and failures following…
The FDA is warning of potentially deadly endoleaks linked to endovascular graft systems, and call for patients with such systems to be closely monitored.
A new study links respiratory tract infections to an increased risk of bleeding events in patients taking commonly used blood thinners.
A new study find Brilinta can reduce the risk of repeat strokes in some patients who are genetically resistant to blood thinners, but also may increase bleeding risks.
New research indicates users of Xarelto face a greater risk of brain bleeds and strokes than those who take Eliquis.
Users of the blood thinner Xarelto had higher risks of recurrent venous thromboembolism and higher risks of bleeding events than those taking Eliquis, according to the findings of a new…